CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Activity
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

26 hedge funds and large institutions have $3.56M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
–
Closed
1
Calls
$4.83M
Puts
–
Net Calls
+$4.83M
Net Calls Change
-$47K

Top Buyers

1
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.61M
2
MF
2
Magnetar Financial
Illinois
$25K
3
Parallax Volatility Advisers
3
Parallax Volatility Advisers
California
$47K
4
CAC
4
Cowen and Company
New York
$9K
5
EFI
5
EHP Funds Inc
Canada
$12K

Top Sellers

1
WP
1
Woodline Partners
California
$0
2
HCM
2
Highbridge Capital Management
New York
$0
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$8K
Name Holding Trade Value Shares
Change 		Shares
Change %
WP
26
Woodline Partners
California
– -$39K -437,431 Closed
HCM
27
Highbridge Capital Management
New York
– -$33K – –
1
2